For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very abnormal ...

ATLANTA--(BUSINESS WIRE)--The Rheumatology Research Foundation is pleased to announce its latest outreach initiative, the Rheumatology Lab. Through this new online resource, the Foundation can ...

Please provide your email address to receive an email when new articles are posted on . Patients with rheumatic and musculoskeletal diseases rated “knowing when the medication is not working” as ...

Diagnosis of rheumatoid arthritis (RA) is largely clinical, based on key historic and physical findings and serial observation of symptoms, signs and response to therapies. Observation during the ...